Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C: A Nationwide Survey in Taiwan - Yu, Ming-Lung; Yeh, Ming-Lun; Tsai, Pei-Chien; Huang, Ching-I.; Huang, Jee-Fu; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Lin, Wen-Yi; Hou, Nai-Jen; et al. (Medicine (Baltimore), 2015)
Keywords: Adult; Aged; Antiviral Agents - administration & dosage; Antiviral Agents - adverse effects; Antiviral Agents - therapeutic use; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hepatitis C, Chronic - drug therapy; Hepatitis C, Chronic - epidemiology; Hepatitis C, Chronic - therapy; Humans; Interferon-alpha - administration & dosage; Interferon-alpha - adverse effects; Interferon-alpha - therapeutic use; Male; Medication Adherence; Middle Aged; Observational Study; Polyethylene Glycols - administration & dosage; Polyethylene Glycols - adverse effects; Polyethylene Glycols - therapeutic use; Prevalence; Prospective Studies; Recombinant Proteins - administration & dosage; Recombinant Proteins - adverse effects; Recombinant Proteins - therapeutic use; Ribavirin - administration & dosage; Ribavirin - adverse effects; Ribavirin - therapeutic use; Taiwan - epidemiology